DeepView® System highlighted at the European Burns Association Congress

Rhea-AI Summary

Spectral AI (NASDAQ: MDAI) showcased its DeepView® System at the European Burns Association (EBA) Congress in Berlin, Germany. The AI-powered medical diagnostics technology was featured in six key presentations and posters from various international medical institutions, primarily focusing on burn wound assessment and treatment.

Notable presentations included studies from the North Bristol NHS Trust, Louisiana State University, and the Royal Victoria Infirmary, demonstrating the system's application in real-world settings. The research highlighted DeepView's capabilities in burn depth assessment, wound healing potential prediction, and patient experience measurements using AI-enhanced multispectral imaging.

DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the European Burns Association (EBA) conference, held from September 3rd – 6th in Berlin, Germany. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across the globe.

Key Presentations and Posters at EBA:

• Multispectral Imaging and Assessment of Burns Healing Potential: A Prospective Real-World Study to assess the DeepView Snapshot Imaging Platform – Sam Snelling, North Bristol NHS Trust, Bristol, United Kingdom
• The First Reader Study of Burn Wounds with Predictive Artificial Intelligence Analysis – Victoria Miles, Louisiana State University Health and Science Center, New Orleans, US
• Artificial Intelligence-Enhanced Multispectral Imaging for Burn Wound Assessment: Insights from a Multi-Centre UK Trial – Mr. Leslie Poh Hong Tan, Royal Victoria Infirmary, Newcastle, United Kingdom
• Early Experiences of the DeepView System wound imaging technology in a UK regional burn centre – Megan Beese, Queens Elizabeth Hospital, Birmingham, United Kingdom
• Patient Experience of Using Artificial Intelligence-Enhanced Multispectral Imaging to Measure Burn Depth: A Regional Burns Centre Review – Miriam Nyeko-Lacek, Manchester University NHS Foundation Trust, United Kingdom
• Preliminary Experience Using Artificial Intelligence and Multispectral Imaging for Burn Depth Assessment – Nicholas Solanki, Burns Unit Royal Adelaide Hospital, Adelaide, Australia

Mr. Chris Lewis, Consultant Burn and Plastic Surgeon from Royal Victory Infirmary in Newcastle, said “With multiple presentations and posters from my team, colleagues and fellow users of DeepView in the United Kingdom, I was excited to see the results of their research and the interest by the European Burn Specialists. Our institution, as an early adopter, continues to use and see the value of the DeepView technology and we look forward to continuing to develop research and share our findings.”

The European Burns Association Congress is a non-profit forum uniting specialists, researchers, and allied professionals to share knowledge, advance research, and promote best practices in burn prevention and treatment across Europe.

Dr. J. Michael DiMaio, Chairman of the Board of Spectral AI, expressed pride in the Company’s role at the conference: “I am pleased with the DeepView System’s reception and results from our initial placement in the United Kingdom. We continue to seek physician feedback and support to bring this advanced burn wound technology to the worldwide market.”

About Spectral AI

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown^®” with its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.

Forward-Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements. 

Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. 

For Media and Investor Relations, please contact:

David Kugelman
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: dk@atlcp.com

FAQ

What was presented about Spectral AI's DeepView System at the European Burns Association Congress 2025?

The DeepView System was featured in six presentations and posters from various medical institutions, focusing on burn wound assessment, healing potential prediction, and patient experience using AI-enhanced multispectral imaging.

Which medical institutions presented research on Spectral AI's (MDAI) DeepView System?

Research was presented by institutions including North Bristol NHS Trust, Louisiana State University, Royal Victoria Infirmary, Queens Elizabeth Hospital, Manchester University NHS Foundation Trust, and Burns Unit Royal Adelaide Hospital.

What is the purpose of Spectral AI's DeepView System?

The DeepView System is an AI-powered medical diagnostics technology designed for burn wound assessment and treatment decisions, utilizing multispectral imaging for faster and more accurate diagnosis.

What feedback did medical professionals give about Spectral AI's DeepView System?

Chris Lewis, Consultant from Royal Victory Infirmary, noted that their institution continues to see value in the DeepView technology as an early adopter, while Dr. DiMaio expressed satisfaction with the system's reception and results from initial UK placement.